Skip to main content
Log in

The clinical application of preimplantation genetic diagnosis for the patient affected by congenital contractural arachnodactyly and spinal and bulbar muscular atrophy

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To investigate the usefulness of preimplantation genetic diagnosis (PGD) for the patient affected by congenital contractural arachnodactyly (CCA) and spinal and bulbar muscular atrophy (SBMA).

Methods

Multiple displacement amplification (MDA) was performed for whole genome amplification (WGA) of biopsied trophectoderm (TE) cells. Direct mutation detection by sequencing and next-generation sequencing (NGS)-based single nucleotide polymorphism (SNP) haplotyping were used for CCA diagnosis. Direct sequencing of the PCR products and sex determination by amplification of sex-determining region Y (SRY) gene were used for SBMA diagnosis. After PGD, the unaffected blastocyst (B4) was transferred in the following frozen embryo transfer (FET).

Results

In this PGD cycle, sixteen MII oocytes were inseminated by ICSI with testicular spermatozoa. Four blastocysts (B4, B5, B10, B13) were utilized for TE cell biopsy on day 5 after ICSI. After PGD, B4 was unaffected by CCA and SBMA. B5 was affected by CCA and carried SBMA. B10 was unaffected by CCA and carried SBMA. B13 was affected by CCA and unaffected by SBMA. B4 was the only unaffected blastocyst and transferred into the uterus for the subsequent FET cycle. The accuracy of PGD was confirmed by amniocentesis at 21 weeks of gestation. A healthy boy weighing 2850 g was born by cesarean section at the 38th week of gestation.

Conclusions

PGD is a valid screening tool for patienst affected of CCA and SBMA to prevent transmission of these genetic diseases from parents to children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990;344:768–70.

    Article  CAS  PubMed  Google Scholar 

  2. De Rycke M, Belva F, Goossens V, Moutou C, SenGupta SB, Traeger-Synodinos J, et al. ESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011. Hum Reprod. 2015;30:1763–89.

    Article  PubMed  Google Scholar 

  3. Eldar-Geva T, Srebnik N, Altarescu G, Varshaver I, Brooks B, Levy-Lahad E, et al. Neonatal outcome after preimplantation genetic diagnosis. Fertil Steril. 2014;102:1016–21.

    Article  PubMed  Google Scholar 

  4. Desmyttere S, De Rycke M, Staessen C, Liebaers I, De Schrijver F, Verpoest W, et al. Neonatal follow-up of 995 consecutively born children after embryo biopsy for PGD. Hum Reprod. 2012;27:288–93.

    Article  CAS  PubMed  Google Scholar 

  5. Jurko Jr A, Krsiakova J, Minarik M, Tonhajzerova I. Congenital contractural arachnodactyly (Beals-Hecht syndrome): a rare connective tissue disorder. Wien Klin Wochenschr. 2013;125:288–90.

    Article  PubMed  Google Scholar 

  6. Tunçbilek E, Alanay Y. Congenital contractural arachnodactyly (Beals syndrome). Orphanet J Rare Dis. 2006;1:20–2.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Liu W, Zhao N, Li XF, Wang H, Sui Y, Lu YP, et al. A novel FBN2 mutation in a Chinese family with congenital contractural arachnodactyly. FEBS Open Bio. 2015;5:163–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Frédéric MY, Monino C, Marschall C, Hamroun D, Faivre L, Jondeau G, et al. The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations. Hum Mutat. 2009;30:181–90.

    Article  PubMed  Google Scholar 

  9. Putnam EA, Zhang H, Ramirez F, Milewicz DM. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet. 1995;11:456–8.

    Article  CAS  PubMed  Google Scholar 

  10. Gupta PA, Wallis DD, Chin TO, Northrup H, Tran-Fadulu VT, Towbin JA, et al. FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly. J Med Genet. 2004;41:e56–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Inbar-Feigenberg M, Meirowitz N, Nanda D, Toi A, Okun N, Chitayat D. Beals syndrome (congenital contractural arachnodactyly): prenatal ultrasound findings and molecular analysis. Ultrasound Obstet Gynecol. 2014;44:486–90.

    Article  CAS  PubMed  Google Scholar 

  12. Kölble N, Wisser J, Babcock D, Maslen C, Huch R, Steinmann B. Prenatal ultrasound findings in a fetus with congenital contractural arachnodactyly. Ultrasound Obstet Gynecol. 2002;20:395–9.

    Article  PubMed  Google Scholar 

  13. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671–80.

    Article  CAS  PubMed  Google Scholar 

  14. Grunseich C, Kats IR, Bott LC, Rinaldi C, Kokkinis A, Fox D, et al. Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat. Neuromuscul Disord. 2014;24:978–81.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sinclair R, Greenland KJ, Egmond S, Hoedemaker C, Chapman A, Zajac JD. Men with Kennedy disease have a reduced risk of androgenetic alopecia. Br J Dermatol. 2007;157:290–4.

    Article  CAS  PubMed  Google Scholar 

  16. Li M, Miwa S, Kobayashi Y, Merry DE, Yamamoto M, Tanaka F, et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol. 1998;44:249–54.

    Article  CAS  PubMed  Google Scholar 

  17. Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC. The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod. 2009;24:1221–8.

    Article  CAS  PubMed  Google Scholar 

  18. Harper JC, Wilton L, Traeger-Synodinos J, Goossens V, Moutou C, SenGupta SB, et al. The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update. 2012;18:234–47.

    Article  CAS  PubMed  Google Scholar 

  19. Kokkali G, Traeger-Synodinos J, Vrettou C, Stavrou D, Jones GM, Cram DS, et al. Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study. Hum Reprod. 2007;22:1443–9.

    Article  CAS  PubMed  Google Scholar 

  20. Renwick PJ, Trussler J, Ostad-Saffari E, Fassihi H, Black C, Braude P, et al. Proof of principle and first cases using preimplantation genetic haplotyping—a paradigm shift for embryo diagnosis. Reprod Biomed Online. 2006;13:110–9.

    Article  CAS  PubMed  Google Scholar 

  21. Qubbaj W, Al-Swaid A, Al-Hassan S, Awartani K, Deek H, Coskun S. First successful application of preimplantation genetic diagnosis and haplotyping for congenital hyperinsulinism. Reprod Biomed Online. 2011;22:72–9.

    Article  CAS  PubMed  Google Scholar 

  22. Renwick P, Trussler J, Lashwood A, Braude P, Ogilvie CM. Preimplantation genetic haplotyping: 127 diagnostic cycles demonstrating a robust, efficient alternative to direct mutation testing on single cells. Reprod Biomed Online. 2010;20:470–6.

    Article  PubMed  Google Scholar 

  23. Chang LJ, Huang CC, Tsai YY, Hung CC, Fang MY, Lin YC, et al. Blastocyst biopsy and vitrification are effective for preimplantation genetic diagnosis of monogenic diseases. Hum Reprod. 2013;28:1435–44.

    Article  PubMed  Google Scholar 

  24. Chen YL, Hung CC, Lin SY, Fang MY, Tsai YY, Chang LJ, et al. Successful application of the strategy of blastocyst biopsy, vitrification, whole genome amplification, and thawed embryo transfer for preimplantation genetic diagnosis of neurofibromatosis type 1. Taiwan J Obstet Gynecol. 2011;50:74–8.

    Article  PubMed  Google Scholar 

  25. Altarescu G, Zeevi DA, Zeligson S, Perlberg S, Eldar-Geva T, Margalioth EJ, et al. Familial haplotyping and embryo analysis for preimplantation genetic diagnosis (PGD) using DNA microarrays: a proof of principle study. J Assist Reprod Genet. 2013;30:1595–603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Altarescu G, Eldar Geva T, Brooks B, Margalioth E, Levy-Lahad E, Renbaum P. PGD on a recombinant allele: crossover between the TSC2 gene and ‘linked’ markers impairs accurate diagnosis. Prenat Diagn. 2008;28:929–33.

    Article  CAS  PubMed  Google Scholar 

  27. Kakourou G, Dhanjal S, Daphnis D, Doshi A, Nuttall S, Gotts S, et al. Preimplantation genetic diagnosis for myotonic dystrophy type 1: detection of crossover between the gene and the linked marker APOC2. Prenat Diagn. 2007;27:111–6.

    Article  CAS  PubMed  Google Scholar 

  28. Lewis, R. Human genetics: concepts and applications. McGraw-Hill Higher Education; 2005

  29. La Spada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1992;2:301–4.

    Article  PubMed  Google Scholar 

  30. Dossena M, Bedini G, Rusmini P, Giorgetti E, Canazza A, Tosetti V, et al. Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophy. PLoS One. 2014;9, e112746.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Georgiou I, Sermon K, Lissens W, De Vos A, Platteau P, Lolis D, et al. Preimplantation genetic diagnosis for spinal and bulbar muscular atrophy (SBMA). Hum Genet. 2001;108:494–8.

    Article  CAS  PubMed  Google Scholar 

  32. Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen C, et al. Clinical features of spinal and bulbar muscular atrophy. Brain. 2009;132:3242–51.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank the family for their participation in this study. We are extremely grateful to Peking Jabrehoo Med Tech., Ltd for this work. This work was funded by Medical Science and technology development Foundation, Nanjing Department of Health (YKK15070), and the special grant for clinical medicine science of Jiangsu Province (BL2014003).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Guijun Yan or Haixiang Sun.

Ethics declarations

The couple signed informed consent forms for ICSI treatment, PGD, and follow-up.

This project was approved by the Ethics Committee of the Drum Tower Hospital, which is affiliated to Nanjing University Medical College.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

The URLs for data in this article are as follows:

OMIM, http://www.ncbi.nlm.nih.gov/omim/

1000 Genomes, http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/

Primers design for PGH, https://www.ampliseq.com/

Capsule

A description of a PGD cycle for the diagnosis of CCA and SBMA, resulting in the birth of a healthy boy.

Linjun Chen and Zhenyu Diao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, L., Diao, Z., Xu, Z. et al. The clinical application of preimplantation genetic diagnosis for the patient affected by congenital contractural arachnodactyly and spinal and bulbar muscular atrophy. J Assist Reprod Genet 33, 1459–1466 (2016). https://doi.org/10.1007/s10815-016-0760-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-016-0760-y

Keywords

Navigation